You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
興科蓉醫藥(06833.HK)與北京北大未名生物工程達成戰略合作
格隆匯 09-20 20:32

格隆匯9月20日丨興科蓉醫藥(06833.HK)發佈公告,2019年9月20日,公司與北京北大未名生物工程集團有限公司就訂約方於生物醫藥、疫苗、醫療設備及醫療保健服務領域上的合作訂立無法律約束力的戰略合作協議。

根據合作協議,訂約方將在資本及業務方面於生物醫藥、疫苗、醫療設備及醫療保健服務領域上合作。此外,訂約方將共同研究具體合作模式,並安排實施訂約方的建議合作。根據合作協議,於落實建議合作後,公司將利用其市場資源及銷售渠道協助北京北大未名生物工程推廣北京北大未名生物工程的產品。

北京北大未名生物工程於1992年成立,為北京大學持有的產業集團之一。北京北大未名生物工程主要從事建立生物經濟體系及發展生物經濟業務,並專注於七個重要領域,即生物醫學、生物農業、生物能源、生物環保、生物服務、生物製造及生物智能。

公司訂立合作協議旨在與北京北大未名生物工程制定合作計劃,利用訂約方各自的優勢、資源及專業知識,從而提升集團的競爭力。訂立合作協議與集團的業務策略一致,以發掘生物醫學行業的業務及╱或投資機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account